A diagnostic test to help you find the most suitable cancer treatment

Every cancer is unique due to specific genetic mutations that influence its behaviour. Unfortunately, most public health services do not provide tests to identify such mutations, and they rely on conventional treatment methods which harm both healthy and cancerous cells. Personalised oncology provides recommendations for targeted therapies which are based on the tumour's genetic features, and it minimises damage to healthy cells.

Personalised oncology is designed to assist patients who have received a cancer diagnosis and who are actively seeking targeted therapy options. To undergo the test, it is necessary to provide a tumour or blood sample for analysis. If you are unsure about your eligibility, you can contact our support team for guidance.

Informing your oncologist and securing their consent for collaboration is essential to ensure the best possible outcome. Once the report is ready, the treating oncologist can act on the recommendations and continue treatment with targeted therapies.

The offer of available therapies depends on the country where the patient is being treated, with there being varying levels of accessibility (30–100%).